Table 9 Prevalence of metabolic syndrome according to NCEP-ATP III and AHA/NHLB definitions by previous antipsychotic treatment at baseline, Prev-AP, FAS, N = 642

4

0.6

-

62

30

48.4

35.5 to 61.4

66

25

37.9

26.2 to 50.7

49

23

46.9

32.5 to 61.7

102

45

44.1

34.3 to 54.3

90

38

42.2

31.9 to 53.1

107

52

48.6

38.8 to 58.5

162

34

21.0

15.0 to 28.1

638

247

38.7

34.9 to 42.6

N

n

%

95% CI

4

0.6

-

62

30

48.4

35.5 to 61.4

66

28

42.4

30.3 to 55.2

49

25

51.0

36.3 to 65.6

102

50

49.0

39.0 to 59.1

90

39

43.3

32.9 to 54.2

107

61

57.0

47.1 to 66.5

162

40

24.7

18.3 to 32.1

638

273

42.8

38.9 to 46.7